Epstein-Barr virus and cancer risk study
Part of Cancer clinical trials.
This study looks at how Epstein-Barr virus (a common virus) may be linked to cancer risk. If you live in Zhongshan or Wuzhou City and are generally healthy, you may be able to join and help researchers learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Zhongshan City or Wuzhou City, China.
- You have never been diagnosed with cancer before.
- You are in good physical health, mentally aware, and willing to complete the study's follow-up visits.
- You do not have serious heart, liver, or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks healthy adults in Nanjing over three years to see if routine checkups and blood tests can detect early signs of disease. Participants will give blood samples, fill out health questionnaires, and have yearly physicals.
This study tests an Epstein-Barr virus (EBV) blood antibody and an EBV DNA test to help screen people at higher risk for nasopharyngeal cancer. It may find signs earlier in certain families where cancer runs.
This study screens people in certain cities to see whether signs in the blood related to a virus (EBV) can help find nasopharyngeal cancer earlier. It may help identify higher-risk people so they can be checked sooner.
This study compares three different blood tests to see which works best for spotting nasopharyngeal cancer early in people at higher risk. If you live in certain areas of China, you may be able to join.
This study compares different ways to screen for liver cancer in people with chronic Hepatitis B. It is for adults living in Zhongshan City, China, who are 35 or older and have tested positive for Hepatitis B surface antigen (HBsAg). The goal is to find the best method to catch liver cancer early.
This trial tests a new mRNA-based treatment for people with Epstein-Barr virus (EBV) related diseases, such as certain cancers or EBV illness after a transplant. The goal is to see if the treatment can help your immune system fight the virus and the disease.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.